News

Anheuser-Busch InBev embroiled in Caribbean "poison pill" takeover row

Most popular

What will be Pernod Ricard's priorities?

Why consumers want more experiential marketing

What are Diageo's priorities for the years ahead?

Bar Nøne launch proves Coca-Cola is faster

MORE

As Anheuser-Busch InBev awaits the green light from regulators over its SABMiller acquisition, its Brazilian subsidiary AmBev is battling investors in a fight for control of a Caribbean beverage company.


Related Content

Anheuser-Busch InBev names new CMO, reduces regional management zones

Anheuser-Busch InBev names new CMO, reduces regional management zones...

Anheuser-Busch InBev in Africa - Focus

Anheuser-Busch InBev in Africa - Focus...

Anheuser-Busch InBev moves closer to Craft Brew Alliance buy - analyst

Anheuser-Busch InBev moves closer to Craft Brew Alliance buy - analyst...

Anheuser-Busch InBev full-year 2017 results - Preview

Anheuser-Busch InBev full-year 2017 results - Preview...

Oops! This article is copy protected.

Why can’t I copy the text on this page?

The ability to copy articles is specially reserved for people who are part of a group membership.

How do I become a group member?

To find out how you and your team can copy and share articles and save money as part of a group membership call Sean Clinton on
+44 (0)1527 573 736 or complete this form..



Forgot your password?